Colon cancer, which is caused by cancer of the colon and rectum, ranks third in worldwide mortality charts according to the World Health Organization (WHO).
The high levels of colon cancer are associated with lifestyle factors such as overconsumption of processed meats, low fruit & vegetable intake, lack of physical activity, obesity, cigarette smoking, and excessive alcohol consumption.
Tests such as fecal immunochemical tests (FIT) are critical in assessing the chances of colon cancer for an individual. Patient screening, diagnosis, and treatment markets are dominated by hospitals and clinics due to their central role.
As awareness about colon cancer screening increases and screening programs become more widespread, the demand for these tests in hospitals and clinics is expected to rise, further strengthening their dominance in the global In-vitro Colorectal Cancer Screening Tests market.
Colorectal cancer is a type of cancer that affects the colon or rectum, accounting for approximately 10% of all cancer cases. The incidence of colorectal cancer has been declining in high-income countries, thanks mainly to effective screening programs.
Fecal immunochemical test (FIT) detects hidden blood in stool from the lower intestine. It is recommended that this test should be done annually. It can be done in the privacy of the home.
Colorectal cancer and polyp cells often have DNA mutations (changes) in certain genes. Cells with these mutations are frequently shed in the stool and may be detectable by a test. Cologuard, the only test currently available in the U.S., tests for both DNA changes and blood in stool (FIT).
| Attribute | Detail |
|---|---|
| Drivers |
|
In-vitro colon cancer screening tests provide a convenient, non-invasive method to detect biomarkers associated with colon cancer in biological samples such as blood and stool. These tests provide medical professionals with valuable insight into a patient's risk of developing colon cancer, allowing for timely intervention and treatment.
Colon cancer is often diagnosed at an advanced stage, leaving limited treatment options. The incidence and impact of colon cancer can be significantly reduced by implementing primary prevention strategies such as adopting a healthy lifestyle, avoiding risk factors, and early detection through screening.
Thus, the surge in number of colon cancer screening tests is expected to propel the in-vitro colorectal cancer screening tests market growth during the forecast period.
The in-vitro colorectal cancer screening tests market segmentation based on test type includes fecal DNA test kits, fecal immunochemical test (FIT), Guaiac Fecal Occult Blood Test (gFOBT) kits, and others. The fecal immunochemical test (FIT) segment dominates the market. FIT positivity reported by different screening programs may also reflect many risk factors.
An advantage of FIT is that some brands of FIT can provide quantitative Hb results; however, most countries using FIT for CRC population screening only report qualitative test results, even when quantitative tests are used.
FIT could potentially be used effectively in symptomatic patients and high-risk populations to achieve more efficient and cost-effective use of colonoscopy.
Based on end-user, the in-vitro colorectal cancer screening tests market report reveals that the hospitals & clinics segment is currently dominating, driven by several key factors.
Hospitals and clinics act as the primary point of contact for patients seeking colon cancer screening, diagnosis, and treatment. These facilities typically have the necessary infrastructure, resources, and qualified medical professionals to effectively perform in-vitro screening tests.
Additionally, hospitals and clinics often receive referrals from general practitioners and other healthcare providers, further increasing their importance in this market segment.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the in-vitro colorectal cancer screening tests industry analysis, North America is dominant in the landscape. The increase in number of colorectal cancer patients in the United States is expected to expand the in-vitro colorectal cancer screening tests market share of North America during the forecast period.
In the United States, colorectal cancer is the third leading cause of cancer deaths in men and the fourth leading cause of cancer deaths in women, but when both men and women are combined, it is the second leading cause of cancer deaths.
The American Cancer Society estimates that there will be approximately 106,590 new cases of colon cancer and 46,220 new cases of rectal cancer in the United States in 2024.
Furthermore, the increase in number of screening tests in Europe and Asian countries in addition to North America is expected to drive the in-vitro colon cancer screening tests market revenue.
According to the in-vitro colorectal cancer screening tests market report, the market is highly competitive and has a strong presence of key players. Leading players are adopting strategies such as development of products and collaborative partnerships.
Abbott Laboratories, Thermofisher Scientific Inc., Eiken Chemical Co., Ltd, Qiagen, Quest Diagnostics Incorporated, Sentinel CH. SpA, Quidel Corporation, Freenome Holdings, Inc., Immunostics, Inc., and BTNX, Inc. are the prominent In-vitro colorectal cancer screening tests market manufacturers profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Market Value in 2023 | US$ 1.2 Bn |
| Forecast (Value) in 2034 | US$ 2.5 Bn |
| Growth Rate (CAGR) | 7.1% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It provides segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 1.2 Bn in 2023
It is projected to reach more than US$ 2.5 Bn by the end of 2034
The CAGR is anticipated to be 7.1% from 2024 to 2034
Surge in prevalence of colorectal cancer
Based on test type, the fecal immunochemical test (FIT) segment accounted for major share in 2023
North America is expected to account for major share during the forecast period
Abbott Laboratories, Thermofisher Scientific Inc., Eiken Chemical Co., Ltd, Qiagen, Quest Diagnostics Incorporated, Sentinel CH. SpA, Quidel Corporation, Freenome Holdings, Inc., Immunostics, Inc., and BTNX, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In-vitro Colorectal Cancer Screening Tests Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Porter’s Five Force Analysis
5.2. Key Industry Events
5.3. Prevalence of Cancer
6. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, By Test Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Test Type, 2020-2034
6.3.1. Fecal DNA Test Kits
6.3.2. Fecal immunochemical Test (FIT)
6.3.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
6.3.4. Others
6.4. Market Attractiveness By Test Type
7. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, By End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By End-user, 2020-2034
7.3.1. Hospitals & Clinics
7.3.2. Diagnostic Centers
7.3.3. Others
7.4. Market Attractiveness By End-user
8. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Market Value Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness By Country/Region
9. North America In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast By Test Type, 2020-2034
9.2.1. Fecal DNA Test Kits
9.2.2. Fecal immunochemical Test (FIT)
9.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
9.2.4. Others
9.3. Market Value Forecast By End-user, 2020-2034
9.3.1. Hospitals & Clinics
9.3.2. Diagnostic Centers
9.3.3. Others
9.4. Market Value Forecast By Country, 2020-2034
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Test Type
9.5.2. By End-user
9.5.3. By Country
10. Europe In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Test Type, 2020-2034
10.2.1. Fecal DNA Test Kits
10.2.2. Fecal immunochemical Test (FIT)
10.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
10.2.4. Others
10.3. Market Value Forecast By End-user, 2020-2034
10.3.1. Hospitals & Clinics
10.3.2. Diagnostic Centers
10.3.3. Others
10.4. Market Value Forecast By Country, 2020-2034
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Test Type
10.5.2. By End-user
10.5.3. By Country
11. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Test Type, 2020-2034
11.2.1. Fecal DNA Test Kits
11.2.2. Fecal immunochemical Test (FIT)
11.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
11.2.4. Others
11.3. Market Value Forecast By End-user, 2020-2034
11.3.1. Hospitals & Clinics
11.3.2. Diagnostic Centers
11.3.3. Others
11.4. Market Value Forecast By Country, 2020-2034
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Test Type
11.5.2. By End-user
11.5.3. By Country
12. Latin America In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Test Type, 2020-2034
12.2.1. Fecal DNA Test Kits
12.2.2. Fecal immunochemical Test (FIT)
12.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
12.2.4. Others
12.3. Market Value Forecast By End-user, 2020-2034
12.3.1. Hospitals & Clinics
12.3.2. Diagnostic Centers
12.3.3. Others
12.4. Market Value Forecast By Country, 2020-2034
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Test Type
12.5.2. By End-user
12.5.3. By Country
13. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Test Type, 2020-2034
13.2.1. Fecal DNA Test Kits
13.2.2. Fecal immunochemical Test (FIT)
13.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
13.2.4. Others
13.3. Market Value Forecast By End-user, 2020-2034
13.3.1. Hospitals & Clinics
13.3.2. Diagnostic Centers
13.3.3. Others
13.4. Market Value Forecast By Country, 2020-2034
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Test Type
13.5.2. By End-user
13.5.3. By Country
14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis By Company (2023)
14.3. Company Profiles
14.3.1. Abbott Laboratories
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Thermofisher Scientific Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Eiken Chemical Co., Ltd
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Qiagen
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Quest Diagnostics Incorporated
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Sentinel CH. SpA
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Quidel Corporation
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Freenome Holdings, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.9. Immunostics, Inc.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.10. BTNX, Inc.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
List of Tables
Table 01: Global In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 02: Global In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Test Type, 2020-2034
Table 03: Global In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Region, 2020-2034
Table 04: North America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 05: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 06: Europe In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 07: Latin America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 08: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 09: North America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 10: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Test Type, 2020-2034
Table 11: Europe In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Test Type, 2020-2034
Table 12: Latin America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Test Type, 2020-2034
Table 13: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Test Type, 2020-2034
Table 14: North America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Test Type, 2020-2034
Table 15: Europe In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 16: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 17: Latin America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
List of Figures
Figure 01: Global In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by Test Type, 2023 and 2034
Figure 03: Global In-vitro Colorectal Cancer Screening Tests Market Share Analysis, by Test Type, 2023
Figure 04: Global In-vitro Colorectal Cancer Screening Tests Market Share Analysis, by Test Type, 2034
Figure 05: Global In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 06: Global In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 07: Global In-vitro Colorectal Cancer Screening Tests Market Share Analysis, by End-user, 2023
Figure 08: Global In-vitro Colorectal Cancer Screening Tests Market Share Analysis, by End-user, 2034
Figure 09: Global In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 10: Global In-vitro Colorectal Cancer Screening Tests Market Value Share Analysis, by Region, 2023 and 2034
Figure 11: Global In-vitro Colorectal Cancer Screening Tests Market Share Analysis, by Region, 2023
Figure 12: Global In-vitro Colorectal Cancer Screening Tests Market Share Analysis, by Region, 2034
Figure 13: Global In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Region, 2023-2034
Figure 14: North America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 15: North America In-vitro Colorectal Cancer Screening Tests Market Value Share Analysis, by Country, 2023 and 2034
Figure 16: North America In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Country, 2024-2034
Figure 17: North America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by Test Type, 2023 and 2034
Figure 18: North America In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 19: North America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 20: North America In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by End-user, 2024-2034
Figure 21: Europe In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 22: Europe In-vitro Colorectal Cancer Screening Tests Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 23: Europe In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 24: Europe In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by Test Type, 2023 and 2034
Figure 25: Europe In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 26: Europe In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 27: Europe In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by End-user, 2024-2034
Figure 28: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 29: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 31: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by Test Type, 2023 and 2034
Figure 32: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 33: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 34: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by End-user, 2024-2034
Figure 35: Latin America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 36: Latin America In-vitro Colorectal Cancer Screening Tests Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 37: Latin America In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Latin America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by Test Type, 2023 and 2034
Figure 39: Latin America In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 40: Latin America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 41: Latin America In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by End-user, 2024-2034
Figure 42: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 43: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 44: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 45: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by Test Type, 2023 and 2034
Figure 46: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 47: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 48: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
In-vitro Colorectal Cancer Screening Tests Market
